Well that's cheap - I gave a percentage chance of approval and you are hinding behind not giving one for another AD drug that failed.
The reason a drug/biotech fails doesn't really matter to whether our investments pays off or don't. Surely any sensible investor has a risk view and appetite, especially to manage a high risk / return portfolio for overall profit.
So you don't agree with my 35% approval chance for Anavex now and you extrapolate what I might chance my chances to if/when Anavex gets past clock stop two. I don't see where you are going with that, but would like hear what chances of approval you have on Anavex at this point.
I have several times said that mine will go up significantly if/when Anavex gets past clock stop one.
Market Data 
Markets 
AI
